庾建英, 刘继新, 李春丽, 王志丹, 李文娟. 急性脑脑卒中超敏C反应蛋白的动态演变及预后观察[J]. 蚌埠医科大学学报, 2015, 40(4): 453-455. DOI: 10.13898/j.cnki.issn.1000-2200.2015.04.011
    引用本文: 庾建英, 刘继新, 李春丽, 王志丹, 李文娟. 急性脑脑卒中超敏C反应蛋白的动态演变及预后观察[J]. 蚌埠医科大学学报, 2015, 40(4): 453-455. DOI: 10.13898/j.cnki.issn.1000-2200.2015.04.011
    YU Jian-ying, LIU Ji-xin, LI Chun-li, WANG Zhi-dan, LI Wen-juan. The relationship between the dynamic change of high sensitivity C-reactive protein and prognosis in patients with acute stroke[J]. Journal of Bengbu Medical University, 2015, 40(4): 453-455. DOI: 10.13898/j.cnki.issn.1000-2200.2015.04.011
    Citation: YU Jian-ying, LIU Ji-xin, LI Chun-li, WANG Zhi-dan, LI Wen-juan. The relationship between the dynamic change of high sensitivity C-reactive protein and prognosis in patients with acute stroke[J]. Journal of Bengbu Medical University, 2015, 40(4): 453-455. DOI: 10.13898/j.cnki.issn.1000-2200.2015.04.011

    急性脑脑卒中超敏C反应蛋白的动态演变及预后观察

    The relationship between the dynamic change of high sensitivity C-reactive protein and prognosis in patients with acute stroke

    • 摘要: 目的:探讨急性脑卒中患者超敏C反应蛋白(hs-CRP)的动态演变与预后关系。方法:将急性脑卒中患者184例分为缺血性脑卒中102例(缺血组)和出血性脑卒中82例(出血组)。分别于治疗前、治疗后1、2、3、4、6、8周测血hs-CRP水平。并随访1年,观察再发脑卒中情况。结果:2例在发病后2周病死予以剔除。2组患者治疗后1~8周hs-CRP均较治疗前显著降低(P<0.01),治疗后2~8周hs-CRP亦均明显低于治疗后1周(P<0.01)。缺血组患者治疗前后1~8周hs-CRP水平均低于出血组(P<0.05~P<0.01)。2组随访观察1年,hs-CRP持续未恢复正常者再发脑血管病率为44.23%,高于hs-CRP恢复正常者的发生率为11.72%(P<0.01)。结论:急性缺血性脑卒中及急性出血性脑卒中发生后,hs-CRP均明显增高,但急性缺血性脑卒中hs-CRP恢复较急性出血性脑卒中快,hs-CRP持续未恢复者再发脑血管病的概率增高。

       

      Abstract: Objective:To investigate the relationship between the dynamic change of high sensitivity C-reactive protein(hs-CRP) and prognosis in patients with acute stroke.Methods:One hundred and eighty-four patients with acute stroke were divided into the ischemic stroke group(n=102) and hemorrhagic stroke group(n=82).The levels of hs-CRP in all patients were measured before treatment and after 1, 2, 3, 4, 6 and 8 weeks of treatment.The recurrence of stroke was observed during the 1-year of following up.Results:2 patients died after onset two weeks and were removaled.The levels of hs-CRP in two groups after treatment 1 to 8 weeks compared with prior treatment all decreased significantly(P<0.01). The levels of hs-CRP after treatment 2 to 8 weeks compared with post-treatment 1 week decreased significantly too(P<0.01). The level of hs-CRP in ischemic stroke group on prior treatment and post-treatment 1 to 8 weeks compared with hemorrhagic stroke group all decreased significantly(P<0.05~P<0.01).All patients were followed up for 1 year, the recurrence rate of stroke in the patients with abnormal hs-CRP level(44.23%) was higher than that in the patients with normal hs-CRP level(11.72%)(P<0.01).Conclusions:The levels of hs-CRP in ischemic stroke group and hemorrhagic stroke group increase significantly, but the recovery of the level of hs-CRP in ischemic stroke group is more quick than that in hemorrhagic stroke group, and the recurrence rate of stroke in the patients with abnormal hs-CRP level increases.

       

    /

    返回文章
    返回